Home › Funds › Harbor ETF Trust › Harbor Health Care ETF
Fund family: Harbor ETF Trust · Filed by Harbor ETF Trust (CIK 1860434) · SEC series S000077996
Ticker: MEDI (C000238718)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 304 with, 9 against, 12 abstentions (not counted as with management); 3 items carried no recommendation; 1 split votes are in neither count. Shareholder proposals: 4 FOR, 5 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Harbor ETF Trust’s manager page (23,866 ballot items across 25 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Harbor ETF Trust | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 88.4% | 292 | 95.1% | 20,728 |
| Backed environmental and social shareholder proposals at US companies | n/a | 4 | 17.6% | 346 |
Each ballot item this fund voted is set against the votes of the other Harbor ETF Trust funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most Harbor ETF Trust funds on all 61 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 80.9% of this fund’s 325 such votes could be given a sector; the other 62 (19.1%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 249 | 9 | 3.6% |
| Industrials | 14 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 198 | 0 |
| Audit-related | 36 | 0 |
| Say-on-Pay | 36 | 0 |
| Corporate Governance | 22 | 5 |
| Capital Structure | 15 | 0 |
| Compensation | 12 | 0 |
| Other | 7 | 0 |
| Other Social Issues | 3 | 2 |
| Human Rights or Human Capital/workforce | 2 | 2 |
| Shareholder Rights and Defenses | 2 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| ABIVAX SA | May 11, 2026 | $23M | 2 | 0 |
| ELI LILLY AND COMPANY | May 4, 2026 | $7M | 10 | 2 |
| ABBVIE INC. | May 8, 2026 | $3M | 8 | 1 |
| RHYTHM PHARMACEUTICALS, INC. | June 24, 2026 | $1M | 4 | 0 |
| VAXCYTE, INC. | June 15, 2026 | $1M | 5 | 0 |
| INTUITIVE SURGICAL, INC. | April 30, 2026 | $1M | 13 | 0 |
| DANAHER CORPORATION | May 5, 2026 | $978,888 | 14 | 0 |
| NATERA, INC. | June 11, 2026 | $906,404 | 8 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 4, 2026 | ELI LILLY AND COMPANY | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | For | Against |
| May 4, 2026 | ELI LILLY AND COMPANY | Shareholder proposal to prepare an annual lobbying report. Shareholder proposal | Against | For |
| May 8, 2026 | ABBVIE INC. | Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposal | For | Against |
| May 12, 2026 | IDEXX LABORATORIES, INC. | Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting (Proposal Six). Shareholder proposal | For | Against |
| May 26, 2026 | MERCK & CO., INC. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | MERCK & CO., INC. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| June 1, 2026 | UNITEDHEALTH GROUP INCORPORATED | If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposal | Against | For |
| May 13, 2026 | VERTEX PHARMACEUTICALS INCORPORATED | Shareholder Proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposal | For | Against |
333 ballot items at 37 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Harbor Health Care ETF (MEDI) voted at 37 shareholder meetings of 37 companies, on 333 ballot items in all. Where management made a recommendation, the fund followed it on 93.5% of the items and voted against it 9 times. Its most frequent area of disagreement was corporate governance (5 of its votes against management). It voted on 9 shareholder proposals. It voted FOR the board's own proposals less often than Harbor ETF Trust's funds as a whole (88.4% against 95.1%). It voted the same way as most Harbor ETF Trust funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Harbor ETF Trust’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.